Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 VALUE CHAIN ANALYSIS:
4.3 COMPETITIVE ANALYSIS
4.4 BRAND ANALYSIS
4.5 ECOSYSTEM MAPS
4.6 TECHNOLOGICAL TRENDS
4.7 TOP WINNING STRATEGIES
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING
5.1.4 INCREASING GOVERNMENT INITIATIVES
5.2 RESTRAINTS
5.2.1 STRICT REGULATORY FRAMEWORK
5.2.2 LACK OF STANDARDIZATION
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS
5.4 CHALLENGES
5.4.1 LACK OF SKILLED PROFESSIONALS
5.4.2 RISK TO PATIENT'S DATA SECURITY
6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE
6.1 OVERVIEW
6.2 CARDIAC MONITORING DEVICES
6.3 BLOOD PRESSURE MONITORING DEVICES
6.4 MULTI-PARAMETER MONITORING DEVICES
6.5 BLOOD GLUCOSE MONITORING DEVICES
6.6 RESPIRATORY MONITORING DEVICES
6.7 NEUROLOGICAL MONITORING DEVICES
6.8 OTHERS
7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 CARDIOVASCULAR DISEASE
7.2.1 CORONARY HEART DISEASE
7.2.2 STROKE
7.2.3 PERIPHERAL ARTERIAL DISEASE
7.2.4 AORTIC DISEASE
7.2.5 OTHERS
7.3 DIABETES
7.4 ONCOLOGY
7.5 OTHERS
8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER
8.1 OVERVIEW
8.2 HOME HEALTHCARE PATIENTS
8.2.1 BLOOD GLUCOSE MONITORING DEVICES
8.2.2 CARDIAC MONITORING DEVICES
8.2.3 BLOOD PRESSURE MONITORING DEVICES
8.2.4 MULTI-PARAMETER MONITORING DEVICES
8.2.5 RESPIRATORY MONITORING DEVICES
8.2.6 NEUROLOGICAL MONITORING DEVICES
8.2.7 OTHERS
8.3 AMBULATORY PATIENTS
8.3.1 MULTI-PARAMETER MONITORING DEVICES
8.3.2 RESPIRATORY MONITORING DEVICES
8.3.3 CARDIAC MONITORING DEVICES
8.3.4 BLOOD PRESSURE MONITORING DEVICES
8.3.5 BLOOD GLUCOSE MONITORING DEVICES
8.3.6 NEUROLOGICAL MONITORING DEVICES
8.3.7 OTHERS
8.4 HOSPITAL-BASED PATIENTS
8.4.1 MULTI-PARAMETER MONITORING DEVICES
8.4.2 CARDIAC MONITORING DEVICES
8.4.3 RESPIRATORY MONITORING DEVICES
8.4.4 BLOOD PRESSURE MONITORING DEVICES
8.4.5 BLOOD GLUCOSE MONITORING DEVICES
8.4.6 NEUROLOGICAL MONITORING DEVICES
8.4.7 OTHERS
9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION
9.1 MIDDLE EAST AND AFRICA
9.1.1 SOUTH AFRICA
9.1.2 EGYPT
9.1.3 ISRAEL
9.1.4 UAE
9.1.5 SAUDI ARABIA
9.1.6 REST OF MIDDLE EAST AND AFRICA
10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 DEXCOM, INC.
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENT
12.4 RESMED
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 BIOTRONIK SE & CO. KG
12.5.1 COMPANY SNAPSHOT
12.5.2 COMPANY SHARE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 100 PLUS.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 A&D COMPANY, LIMITED
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 COMPANY SHARE ANALYSIS
12.7.4 PRODUCT PORTFOLIO
12.7.5 RECENT DEVELOPMENT
12.8 AEROTEL MEDICAL SYSTEMS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 ALIVECOR, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 COMPANY SHARE ANALYSIS
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENTS
12.1 BIOBEAT
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 BOSTON SCIENTIFIC CORPORATION
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 COMPANY SHARE ANALYSIS
12.11.4 PRODUCT PORTFOLIO
12.11.5 RECENT DEVELOPMENT
12.12 CARDIOMO
12.12.1 COMPANY SNAPSHOT
12.12.2 PRODUCT PORTFOLIO
12.12.3 RECENT DEVELOPMENTS
12.13 CHRONISENSE MEDICAL, LTD.
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENT
12.14 COACHCARE
12.14.1 COMPANY SNAPSHOT
12.14.2 PRODUCT PORTFOLIO
12.14.3 RECENT DEVELOPMENT
12.15 GENERAL ELECTRIC
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 COMPANY SHARE ANALYSIS
12.15.4 PRODUCT PORTFOLIO
12.15.5 RECENT DEVELOPMENT
12.16 KONINKLIJKE PHILIPS N.V.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 COMPANY SHARE ANALYSIS
12.16.4 PRODUCT PORTFOLIO
12.16.5 RECENT DEVELOPMENT
12.17 MASIMO
12.17.1 COMPANY SNAPSHOT
12.17.2 REVENUE ANALYSIS
12.17.3 COMPANY SHARE ANALYSIS
12.17.4 PRODUCT PORTFOLIO
12.17.5 RECENT DEVELOPMENT
12.18 NETEERA
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT DEVELOPMENT
12.19 NIHON KOHDEN CORPORATION
12.19.1 COMPANY SNAPSHOT
12.19.2 REVENUE ANALYSIS
12.19.3 COMPANY SHARE ANALYSIS
12.19.4 PRODUCT PORTFOLIO
12.19.5 RECENT DEVELOPMENT
12.2 OMRON CORPORATION
12.20.1 COMPANY SNAPSHOT
12.20.2 REVENUE ANALYSIS
12.20.3 COMPANY SHARE ANALYSIS
12.20.4 PRODUCT PORTFOLIO
12.20.5 RECENT DEVELOPMENT
12.21 SENSEONICS, INC.
12.21.1 COMPANY SNAPSHOT
12.21.2 REVENUE ANALYSIS
12.21.3 COMPANY SHARE ANALYSIS
12.21.4 PRODUCT PORTFOLIO
12.21.5 RECENT DEVELOPMENT
12.22 VITALCONNECT
12.22.1 COMPANY SNAPSHOT
12.22.2 PRODUCT PORTFOLIO
12.22.3 RECENT DEVELOPMENT
12.23 VITLS
12.23.1 COMPANY SNAPSHOT
12.23.2 PRODUCT PORTFOLIO
12.23.3 RECENT DEVELOPMENT
12.24 VIVIFY HEALTH INC.
12.24.1 COMPANY SNAPSHOT
12.24.2 PRODUCT PORTFOLIO
12.24.3 RECENT DEVELOPMENTS
12.25 WITHINGS
12.25.1 COMPANY SNAPSHOT
12.25.2 COMPANY SHARE ANALYSIS
12.25.3 PRODUCT PORTFOLIO
12.25.4 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA CARDIAC MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA BLOOD PRESSURE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA MULTI-PARAMETER MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA BLOOD GLUCOSE MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA RESPIRATORY MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA NEUROLOGICAL MONITORING DEVICES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CARDIOVASCULAR DISEASE IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA DIABETES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA ONCOLOGY IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA OTHERS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 30 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 31 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 32 SOUTH AFRICA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 33 SOUTH AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 SOUTH AFRICA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 35 SOUTH AFRICA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 36 SOUTH AFRICA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 37 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 38 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 EGYPT CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 40 EGYPT REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 41 EGYPT HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 42 EGYPT AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 43 EGYPT HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 44 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 45 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 46 ISRAEL CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 47 ISRAEL REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 48 ISRAEL HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 49 ISRAEL AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 50 ISRAEL HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 51 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 52 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 53 UAE CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 54 UAE REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 55 UAE HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 56 UAE AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 57 UAE HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 58 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 59 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 60 SAUDI ARABIA CARDIOVASCULAR DISEASES IN REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 61 SAUDI ARABIA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 62 SAUDI ARABIA HOME HEALTHCARE PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 63 SAUDI ARABIA AMBULATORY PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 64 SAUDI ARABIA HOSPITAL-BASED PATIENTS IN REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
TABLE 65 REST OF MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CARDIAC MONITORING DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET
FIGURE 14 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2022
FIGURE 15 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY DEVICE TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2022
FIGURE 19 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2022
FIGURE 23 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY END USER, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: SNAPSHOT (2022)
FIGURE 27 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022)
FIGURE 28 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2023 & 2030)
FIGURE 29 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: BY COUNTRY (2022 & 2030)
FIGURE 30 MIDDLE EAST AND AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: DEVICE TYPE (2023-2030)
FIGURE 31 MIDDLE EAST & AFRICA REMOTE PATIENT MONITORING AND CARE MARKET: COMPANY SHARE 2022 (%)
